Concepedia

Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib or trastuzumab according to HER2 status

Sylvie Giacchetti, Anne‐Sophie Hamy, Suzette Delaloge, Étienne Brain, Frédérique Berger, Brigitte Sigal‐Zafrani, Marie‐Christine Mathieu, Philippe Bertheau, Jean Marc Guinebretière, Mahasti Saghatchian,

European Journal of Cancer · 2017 · 26 citations · 28 references

DOI

Concepts

References

28

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Stefan Aebi, T. Davidson, Günther Gruber et al. · Annals of Oncology · 2010 · 2.9K citations · Full text

, , +14

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

Gϋnter von Minckwitz, Michael Untch, Jens‐Uwe Blohmer et al. · Journal of Clinical Oncology · 2012 · 2.7K citations

, , +15

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

Luca Gianni, Tadeusz Pieńkowski, Young‐Hyuck Im et al. · The Lancet Oncology · 2011 · 2.4K citations

, , +16

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Alan S. Coates, Eric P. Winer, Aron Goldhirsch et al. · Annals of Oncology · 2015 · 1.8K citations · Full text

, , +17

Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27

Priya Rastogi, Stewart Anderson, Harry D. Bear et al. · Journal of Clinical Oncology · 2008 · 1.8K citations

, , +16